New York, New York--(Newsfile Corp. - December 20, 2024) - Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a shareholder and consumer rights litigation firm, is investigating whether Reckitt Benckiser Group PLC ("Reckitt" or the "Company") (OTC Pink: RBGLY) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws.
Reckitt is a United Kingdom-based, global consumer goods company. To date, over 500 state and federal products liability lawsuits have been filed against Reckitt and its competitor, Abbott Laboratories ("Abbott"), claiming that they failed to adequately warn that premature infants consuming cow milk-based formulas, such as Reckitt's Enfamil and Abbott's Similac, have an increased risk of developing necrotizing enterocolitis ("NEC"), a life-threatening intestinal disease that affects premature or low birth weight infants.
On March 15, 2024, a jury in St. Clair County, Illinois, returned a $60 million verdict against Reckitt in the first NEC lawsuit to be tried to a verdict. On this news, the price of the Company's American Depositary Receipts ("ADRs") dropped $1.87, or nearly 14%, to close at $11.44 per ADR, on heavy trading volume. Then, on July 29, 2024, a jury in St. Louis, Illinois awarded a plaintiff $495 million in damages against Abbott in another NEC lawsuit. On this news, the price of Reckitt's ADRs dropped an additional $1.02, or nearly 9%, to close at $10.64 per ADR, on heavy trading volume.
What You Can Do
If you have purchased Reckitt ADRs, and have suffered a loss, realized or unrealized, and you wish to discuss this investigation, please contact attorney Nicholas Bruno at (888) 398-9312 or at nbruno@scott-scott.com.
About Scott+Scott
Scott+Scott has significant experience in prosecuting major securities, antitrust, and consumer rights actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, Virginia, and Ohio.
This may be considered Attorney Advertising.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/233074
